Search Results

Livongo Health, Inc., (Nasdaq: LVGO) today announced it will release its financial results for its third quarter of fiscal year 2020 on October 28, 2020, after close of the U.S. stock market. Given the pending transaction with Teladoc Health, Livongo is not hosting a conference call in conjunction with its third quarter of 2020 earnings release. About Livongo Livongo empowers people with chronic conditions to live better and healthi

Dexcom CGM to become a core part of Livongo’s solution for delivering personalized health insights and improved clinical outcomes to people with Diabetes

Livongo to Provide Remote Monitoring, Connected Devices Powered by Advanced Data Science, and Personalized Coaching for People with Late-Stage CKD

Teladoc Health (TDOC), the global leader in whole person virtual care, today announced that its shareholders have overwhelmingly showed their support for the merger with Livongo (LVGO) by voting to approve the Teladoc Health charter amendment and share issuance. During Teladoc Health’s Special Meeting of shareholders held earlier today, Teladoc Health’s shareholders approved the Teladoc Health charter amendment and share issuance, with more tha

Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that executives from the Company, together with executives from Teladoc Health, will be presenting at the following upcoming investor conference: Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13 at 8:30 a.m. Eastern Time A live webcast of

Participating health plans and employers can now expand access to Livongo’s leading Diabetes, Hypertension, and Weight Management solutions

Livongo Health, Inc., the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, announced financial results for its first quarter ended March 31, 2020.

Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that executives from the Company will be presenting at the following upcoming investor conferences:

Health consumers can soon access Livongo’s Applied Health Signals Platform for the Whole Person starting at prominent locations and leading pharmacy retailers in Michigan

Livongo Health, Inc. (“Livongo”) (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the pricing of $475.0 million aggregate principal amount of 0.875% convertible senior notes due 2025 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities